3TC	Lamivudine
ABC	Abacavir
ADR	Adverse drug reaction
ALT	Alanine aminotransferase
ART	Antiretroviral therapy
AST	Aspartate aminotransferase
ATV	Atazanavir
BIC	Bictegravir
CD4	Cluster of differentiation 4
CD8	Cluster of differentiation 8
CKD-EPI	Chronic Kidney Disease Epidemiology Collaboration
DDI	Drug-drug interaction
DOR	Doravirine
DOR/3TC/TDF	Doravirine/lamivudine/tenofovir disoproxil fumarate
DRV/c	Darunavir/cobicistat
DTG	Dolutegravir
EFV	Efavirenz
eGFR	Estimated glomerular filtration rate
EVG/c	Elvitegravir/cobicistat
FTC	Emtricitabine
GGT	Gamma-glutamyl transferase
HBsAg	Hepatitis B surface antigen
HBV	Hepatitis B virus
HCV	Hepatitis C virus
HDL-C	High-density lipoprotein cholesterol
HIV	Human immunodeficiency virus
INSTI	Integrase strand transfer inhibitor
IQR	Interquartile range
LDL-C	Low-density lipoprotein cholesterol
NNRTI	Non-nucleoside reverse transcriptase inhibitor
NRTI	Nucleoside/nucleotide reverse transcriptase inhibitor
NVP	Nevirapine
PI	Protease inhibitor
PWH	People with HIV
RAL	Raltegravir
RPV	Rilpivirine
TAF	Tenofovir alafenamide
TDF	Tenofovir disoproxil fumarate